IMB-10035

N/A

Report date: 2025/01/26 18:54:59
NME

Base Information

Drug NameIMB-10035
Drug Alias NameIMB-10035
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAPOBEC3G deaminase modulatorsVirion infectivity factor inhibitors
TargetsVirion infectivity factorAPOBEC3G deaminase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A